What began as research aimed at expanding the limited treatment options for cystinuria, a rare genetic disorder affecting 1 ...
COSTA MESA, Calif., April 21, 2026 /PRNewswire/ -- CerraCap Ventures investment in Nephronomics reflects strategic conviction ...
The finding informed research at Nanjing Medical University, where physicians initiated a first-in-human trial of PADN in ...
Results from the phase 3 LITESPARK-012 trial (NCT04736706) demonstrate that intensifying an established first-line regimen ...
A triplet regimen comprising Merck’s Welireg and PD-1 blockbuster Keytruda and Eisai’s Lenvima flopped in a Phase 3 renal ...
Elevated LDH predicts worse renal and cardiovascular outcomes in advanced CKD without diabetes. Learn how this biomarker ...
Bernie Sanders, found that drug companies involved in price deals with President Donald Trump have continued to raise prices on hundreds of medications. Some new drugs are also launching with very ...
Renin-independent aldosterone production is associated with rapid kidney function decline in adults with hypertension, according to new data.
After prevailing in two kidney cancer trials in the refractory and early-stage settings, Merck & Co.’s blockbuster prospect ...
John Gotti’s grandson Carmine Agnello was sentenced to 15 months behind bars for a $1.1 million dollar COVID fraud, as court ...
Merck and Eisai's experimental combination treatments failed to significantly improve survival or reduce the risk of cancer ...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Eisai today announced results from the Phase 3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results